DYN
Dyne Therapeutics, Inc.
1W: +3.8%
1M: +22.1%
3M: -8.7%
YTD: +2.6%
1Y: +53.2%
3Y: +57.4%
5Y: +17.8%
$18.98
+1.13 (+6.33%)
After Hours: $18.70 (-0.28, -1.48%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$10.7M
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.1B
52W Range6.36-25
Volume2,775,306
Avg Volume2,217,001
Beta1.40
Dividend—
Analyst Ratings
Company Info
CEOJohn G. Cox
Employees192
SectorHealthcare
IndustryBiotechnology
IPO Date2020-09-17
Websitedyne-tx.com
1560 Trapelo Road
Waltham, MA 02451
US
Waltham, MA 02451
US
781 786 8230
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Latest News
Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Average Rating of “Moderate Buy” from Analysts
Dyne Therapeutics (NASDAQ:DYN) Stock Price Up 4.4% – Here’s Why
Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co.
Revolution, Ascendis, Arrowhead among RBC’s top M&A candidates in biotech
HC Wainwright Lifts Earnings Estimates for Dyne Therapeutics
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kersten Dirk | S-Sale | 129,672 | $19.52 | 2026-03-11 |
| Posner Brian S | P-Purchase | 2,000 | $19.35 | 2026-03-11 |
| Kersten Dirk | S-Sale | 9,482 | $18.21 | 2026-03-10 |
| Kersten Dirk | S-Sale | 219,758 | $19.32 | 2026-03-10 |
| Kersten Dirk | S-Sale | 281,858 | $19.80 | 2026-03-10 |